Skip to main content

How we transmitted 5,801.6MW to DISCOs without hitch ― TCN

How we transmitted 5,801.6MW to DISCOs without hitch ― TCN

TCN recovers 600MW Egbin-Ajah transmission line after tower completion

By Chris Ochayi, Abuja

The Managing Director of the Transmission Company of Nigeria, Engr. Sule Abdulaziz has said the company evacuated the country’s highest power generation of 5,801.6 megawatts to Distribution Companies, DISCOs in the first quarter of this year without a hitch.

Engr. Abdulaziz stated this in Abuja while playing host to participants of the Senior Executive Course, Number 43, for the year 2021 of the National Institute for Policy and Strategic Studies, Kuru, Jos.

Meanwhile, Engr. Abdulaziz has urged WAPP member nations to work together for the growth of the power sector in the sub-region. He spoke as chairman of the 49th Executive Board Meeting of the West African Power Pool in Cotonou, Republic of Benin.

ALSO READ: Ugwuanyi reiterates commitment to promotion of human rights, fundamental freedoms of residents

He said TCN was vigorously pursuing its grid maintenance, expansion, and rehabilitation programme, as the transmission company was playing a vital role in providing leadership and commitment to the progress of electricity supply.

He was quoted in a statement by TCN’s spokesperson, Ndidi Mbah, as saying, “I am glad to inform you that due to our commitment in TCN, transmission grid disturbances have been reduced to the barest minimum; grid capacity has also increased.

“Within the first quarter of this year, TCN efficiently wheeled successive all-time peak generation without a hitch, the latest being 5,801.6MW to distribution load centres nationwide.”

Abdulaziz said the TCN had installed several transformers, rehabilitated substations, re-conductored power transmission lines with various projects ongoing.

ALSO READ: Oil Market: Bonny Light price hits $65.85 per barrel after OPEC, Non-OPEC meeting

The TCN boss further noted that the company had continued to collaborate with the power generation and distribution companies towards ensuring that power was made more available to Nigerians.

He urged the institute to consider including officers of the company as participants in subsequent courses, because of the critical role TCN played in electricity supply nationwide and as a public utility.

The chairman of the NIPSS Study Group 1 Senior Course participant delegation to TCN, Rear Admiral E.O. Jaiyeola, said the course was to expose participants to the developing strategic policies for national development.

He said, “For this Senior Executive Course, the task from Mr. President is for us to interrogate the challenges and issues surrounding getting things done as we x-ray various policies and programmes and that is the reason why we are here, particularly focusing on the power sector.”

Vanguard News Nigeria

The post How we transmitted 5,801.6MW to DISCOs without hitch ― TCN appeared first on Vanguard News.


by Temisan Amoye via Vanguard News https://ift.tt/3e6boHL Best Known Member of the Cabinet Wikipedia

Comments

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...